Search results
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 1 day agoEtrumadenant is an investigational small molecule, selective dual antagonist of the A2a and A2b...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 5 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 2 days agoABBV-706 is an ADC targeting SEZ6, a transmembrane protein expressed in various solid tumours,...
Exploring the potential of dietary phytochemicals in cancer prevention
Medical Xpress· 4 days agoCancer remains a significant global health challenge and is a leading cause of mortality worldwide....
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved...
The Pendulum· 2 days agoAfter rigorous evaluation by Scientific Program Committee and ASCO Leadership, LBL-024, a bispecific antibody independently developed by Leads Biolabs with global intellectual property rights ...
Are You Getting Enough Iodine From Your Diet?
Mercola· 19 hours agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine level measured in ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Upregulation of rate-limiting enzymes in cholesterol metabolism by PKCδ mediates endothelial...
Nature· 7 days agoDiabetic foot ulcer (DFU) is a prevalent complication of diabetes that poses significant challenges in terms of treatment and management. It is characterized by heightened endothelial apoptosis ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 3 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
New study highlights senescent cell removal mechanisms of canagliflozin, a sodium glucose...
Medical Xpress· 6 days agoThe process of aging is accompanied by a decline in physiological functions, which can lead to...